Search
Filter Results
- Resource Type
- Article1
- Book1
- Book Digital1
- Result From
- Lane Catalog1
- PubMed1
-
Year
- Journal Title
- J Nutr Sci Vitaminol (Tokyo)1
Search Results
Sort by
- BookFeridoun Karimi-Busheri, editor.Contents:
1. Integration, networking, and global biobanking in the age of new biology
2. The future of biobanking: a conceptual look at how biobanks can respond to the growing human biospecimen needs of researchers
3. Sustainability of biobanks in the future
4. Biobanking: the future of cell preservation strategies
5. Biobanking for personalized medicine
6. A global view of breast tissue banking
7. Biobanking of cerebrospinal fluid for biomarker analysis in neurological diseases
8. Biobanking in the twenty-first century: driving population metrics into biobanking quality
9. Challenges in developing a cancer oriented-biobank: experience from a 17 year-old cancer biobank in Sao Paulo, Brazil
10. China biobanking
11. Establishing an iso-compliant modern cancer-biobank in a developing country: a model for international cooperation
12. Nursing and biobanking
13. A data-centric strategy for modern biobanking
14. The importance of quality patient advocacy to biobanks: a lay perspective from Independent Cancer Patients Voice (ICPV), based in United Kingdom
Index.Digital Access Springer 2015Access via Advances in experimental medicine and biology ; 2015; 864LocationVersionCall NumberItems - ArticleOkano T, Matsuyama N, Kobayashi T, Kuroda E, Kodama S, Matsuo T.J Nutr Sci Vitaminol (Tokyo). 1979;25(6):479-93.In order to obtain a standard compound of 25-hydroxyvitamin D2 (25-OH-D2), a method for isolating in vivo-generated 25-OH-D2 from the blood of rats or rabbits was established by using several steps of preparative high-performance liquid chromatography (HPLC). When the unsaponifiable matter of the plasma obtained from rats or rabbits receiving a large dose of vitamin D2 was applied to the preparative HPLC using a Zorbax SIL column, a peak denoted as peak X was observed on the chromatogram. Since the peak X was thought to be due to 25-OH-D2 from the experiments of time course and dose-response, it was purified by subjecting it to successive preparative HPLC using several kinds of columns. From the results of ultraviolet (UV) absorption spectrum, gas chromatography-mass spectrometry (GC-MS) and mass chromatography, the purified peak X compound was confirmed to be 25-OH-D2. The proposed method for isolating in vivo-generated 25-OH-D2 is very convenient, because the time to perform each HPLC is very short though several steps of HPLC are used.